Diabetes prevention between RAAS inhibition and PPAR-gamma stimulation: the diabetes reduction assessment with ramipril and rosiglitazone medication (DREAM) trial.
作者信息
McFarlane Samy I, Provilus Alfrede, Shin John J
机构信息
Division of Endocrinology, Diabetes and Hypertension, State University of New York Health Science Center and Kings County Hospital Center, Brooklyn, NY 11203, USA.
出版信息
J Cardiometab Syndr. 2007 Spring;2(2):149-50. doi: 10.1111/j.1559-4564.2007.06663.x.
Abstract
摘要
Zotero 插件